Closed loop insulin pump therapy lowers the risk for hypoglycemic coma but increases diabetic ketoacidosis risk among patients with T1D.

Anne Peters, MD, shares her experience in caring for patients during the Los Angeles fires and shares recommendations for ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering. In its latest SEC filing, the company said it was planning to offer 7.5M ...

Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its ...

Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...

Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

Older Montanans especially are struggling because housing costs have skyrocketed since 2021, in part because of the rise of ...

Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...

Donald Trump is a huge fan - but a raft of studies suggest we may not completely escape the negative effects of fizzy drinks ...

The average new issue concession for the IG deals yesterday was 1bp and the average order book was 3.48x subscribed, according to the data. The average move from initial price thoughts to pricing was ...